Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65

Recently, protocols using high-dose melphalan chemotherapy and autologous peripheral blood stem cell transplantation (HDM/SCT) have been developed for the treatment of patients with immunoglobulin light chain (AL) amyloidosis. Although peritransplantation mortality is greater than for other hematolo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Seldin, David C., Anderson, Jennifer J., Skinner, Martha, Malek, Karim, Wright, Daniel G., Quillen, Karen, Finn, Kathleen, Oran, Betul, Sanchorawala, Vaishali
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society of Hematology 2006
Témata:
Transplantation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895463/
https://ncbi.nlm.nih.gov/pubmed/16926284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-06-029728
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky